When stratifying the 5 major genes panel into high risk (BRCA1/2 + PALB2) and moderate-high risk (ATM + CHEK2) for BC, we found that patients with IC were more likely than those with SDC to carry PTVs for BRCA1/2 + PALB2 (Table 2). This evidence concerns the gene CHEK2 and breast cancer.